Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells - Xue, L; Hardman, C; Chen, W; Batty, P; Ogg, G; Erpenbeck, V; Sandham, D (American Thoracic Society, 2018)